Cigna Ebitda vs Selling General Administrative Analysis
CI Stock | USD 336.50 1.50 0.45% |
Cigna Corp financial indicator trend analysis is way more than just evaluating Cigna Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cigna Corp is a good investment. Please check the relationship between Cigna Corp Ebitda and its Selling General Administrative accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cigna Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.
Ebitda vs Selling General Administrative
Ebitda vs Selling General Administrative Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cigna Corp Ebitda account and Selling General Administrative. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Cigna Corp's Ebitda and Selling General Administrative is -0.17. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of Cigna Corp, assuming nothing else is changed. The correlation between historical values of Cigna Corp's Ebitda and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Cigna Corp are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Ebitda i.e., Cigna Corp's Ebitda and Selling General Administrative go up and down completely randomly.
Correlation Coefficient | -0.17 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Ebitda
Selling General Administrative
Most indicators from Cigna Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cigna Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cigna Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.As of now, Cigna Corp's Enterprise Value Multiple is increasing as compared to previous years. The Cigna Corp's current Enterprise Value is estimated to increase to about 120.7 B, while Selling General Administrative is projected to decrease to under 10.2 B.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 140.7B | 148.4B | 159.0B | 166.9B | Total Revenue | 174.3B | 180.6B | 195.2B | 204.9B |
Cigna Corp fundamental ratios Correlations
Click cells to compare fundamentals
Cigna Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cigna Corp fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 155.8B | 155.5B | 154.9B | 143.9B | 152.8B | 89.1B | |
Short Long Term Debt Total | 37.4B | 32.9B | 33.7B | 31.1B | 30.9B | 32.5B | |
Total Stockholder Equity | 45.3B | 50.3B | 47.1B | 44.9B | 46.2B | 48.5B | |
Net Debt | 32.8B | 22.7B | 28.6B | 25.2B | 23.1B | 24.3B | |
Retained Earnings | 20.2B | 28.6B | 32.6B | 37.9B | 41.7B | 43.7B | |
Other Assets | 47.9B | 41.2B | 44.0B | 32.2B | 37.0B | 23.6B | |
Common Stock Shares Outstanding | 379.8M | 368.4M | 341.0M | 313.1M | 296.9M | 365.5M | |
Liabilities And Stockholders Equity | 155.8B | 155.5B | 154.9B | 143.9B | 152.8B | 89.1B | |
Non Current Liabilities Total | 41.3B | 38.5B | 39.5B | 10.8B | 57.7B | 60.6B | |
Other Stockholder Equity | 26.1B | 22.6B | 15.4B | 8.4B | 6.4B | 6.8B | |
Total Liab | 110.4B | 105.1B | 107.7B | 99.0B | 106.4B | 75.1B | |
Total Current Liabilities | 21.1B | 22.2B | 9.2B | 10.8B | 48.7B | 51.2B | |
Property Plant And Equipment Net | 4.4B | 4.2B | 4.0B | 3.8B | 4.1B | 4.3B | |
Non Current Assets Total | 86.5B | 85.4B | 84.8B | 83.0B | 115.4B | 121.2B | |
Non Currrent Assets Other | (1.3B) | (1.3B) | (1.7B) | (1.1B) | 18.2B | 19.1B | |
Cash And Short Term Investments | 5.6B | 11.5B | 6.0B | 6.8B | 7.8B | 14.4B | |
Net Receivables | 15.8B | 12.2B | 15.1B | 22.0B | 17.7B | 10.5B | |
Short Term Investments | 937M | 1.3B | 920M | 905M | 925M | 878.8M | |
Other Current Assets | 11.8B | 2.3B | 12.3B | 2.2B | 6.2B | 5.9B | |
Property Plant And Equipment Gross | 1.6B | 4.6B | 4.4B | 4.2B | 4.8B | 5.1B | |
Total Current Assets | 21.4B | 28.9B | 26.1B | 28.8B | 37.4B | 48.7B | |
Short Term Debt | 5.5B | 3.4B | 2.5B | 3.0B | 2.8B | 2.9B | |
Intangible Assets | 36.6B | 35.2B | 34.1B | 32.5B | 30.9B | 32.4B | |
Accounts Payable | 15.5B | 18.8B | 6.7B | 7.8B | 8.6B | 8.5B | |
Cash | 4.6B | 10.2B | 5.1B | 5.9B | 7.8B | 8.2B | |
Good Will | 44.5B | 44.6B | 44.6B | 45.8B | 44.3B | 46.5B | |
Accumulated Other Comprehensive Income | (941M) | (861M) | (884M) | (1.4B) | (1.9B) | (1.8B) | |
Other Liab | 37.9B | 39.5B | 33.0B | 29.3B | 26.4B | 29.0B | |
Long Term Debt | 31.8B | 29.5B | 31.1B | 28.0B | 28.2B | 29.6B | |
Treasury Stock | (2.2B) | (6.4B) | (14.2B) | (21.8B) | (19.7B) | (18.7B) | |
Property Plant Equipment | 5.0B | 4.2B | 3.7B | 4.1B | 4.8B | 5.0B | |
Retained Earnings Total Equity | 20.2B | 28.6B | 32.6B | 37.9B | 43.6B | 45.7B | |
Inventory | 2.7B | 3.2B | 3.7B | 4.8B | 5.6B | 5.9B | |
Deferred Long Term Liab | 9.4B | 8.9B | 8.3B | 7.8B | 8.9B | 9.4B | |
Other Current Liab | (21.1B) | (22.2B) | (9.2B) | 30.5B | 37.4B | 39.3B | |
Net Tangible Assets | (35.8B) | (29.4B) | (32.8B) | (33.4B) | (30.0B) | (28.5B) |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cigna Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cigna Corp. If investors know Cigna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cigna Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.45) | Dividend Share 5.43 | Earnings Share 10.6 | Revenue Per Share 808.024 | Quarterly Revenue Growth 0.28 |
The market value of Cigna Corp is measured differently than its book value, which is the value of Cigna that is recorded on the company's balance sheet. Investors also form their own opinion of Cigna Corp's value that differs from its market value or its book value, called intrinsic value, which is Cigna Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cigna Corp's market value can be influenced by many factors that don't directly affect Cigna Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cigna Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cigna Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cigna Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.